Lilavati Hospital & Research Center

Details Doctors
Medical Suppliers In Maharashtra

Name :

Lilavati Hospital Research Center

Address  :

A - 791, Bandra Reclamation
Bandra (W)

Town  :

Mumbai

State  :

Maharashtra

Country  :

INDIA

Post Code:

400 050

Phone  :

+ 91 (22) 2675 1628 / 2675 1629

Fax  :

022 – 2640 7655 / 2640 51

Web URL  :

Available

Email  :

lilaweb@lilavatihospital.com
Lilavati Hospital Research Center

Doctors Of Lilavati Hospital & Research Center
Physician
Qualification
Availability
A.Pusalkar
Resident
Ajit R. Menon
Ajit R. Menon
MD, DM
Resident
Amit M. Vora
Amit M. Vora
MD, DNB
Resident
Anil Sharma
Anil Sharma
MD
Resident
Anjula Mahajan
Anjula Mahajan
MD, FRCA
Resident
Ankur J. Shah
Ankur J. Shah
MS, DNB, MNAMS, MRCSEd, FRCS(UK)
Resident
Arun P. Mehra
Arun P. Mehra
MBBS, MS, M.Ch, FIACS
Resident
Arun P.Mehra
Resident
Arun R. Nayak
Arun R. Nayak
MDS
Resident
Arun S. Khatavkar
Arun S. Khatavkar
Resident
Ashish A. Nabar
MD, DNB, PhD, Bd Cert Cardiologist
Resident
Ashish R.Vaidya
Resident
Ashok H. Punjabi
Ashok H. Punjabi
MD(Medicine), DM(Cardiology)
Resident
Ashutosh Ganesh Pusalkar
Ashutosh Ganesh Pusalkar
MS(ENT), FAA(ENT)
Resident
Atul Goel
Resident
Bakul Parulkar
Bakul Parulkar
B.Sc in Audiology & Speech Therapy
Resident
Bhavesh Vajifdar
Bhavesh Vajifdar
MD, DNB, FACC, FESC, FSCAI, FCSI
Resident
Bhimsen Khatri
Bhimsen Khatri
DA
Resident
Chetan N. Oberai
Chetan N. Oberai
MD, DVND, DDV
Resident
Chetan P. Shah
Chetan P. Shah
MD, DM, FACC, FACP
Resident
NEWS
Cancer rising among Indias youth

More youngsters are developing cancer in India doctors said at a conference here on Thursday However most of those affected by the disease remain ignorant about it which leads to delays in diagnosis and treatment they said We are seeing more cases of cancer among teenagers and young adults However not much attention is being paid to it said Dr G... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More